These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

682 related articles for article (PubMed ID: 29935356)

  • 1. Lower miR-340 expression predicts poor prognosis of non-small cell lung cancer and promotes cell proliferation by targeting CDK4.
    Qin Y; Zhou X; Huang C; Li L; Liu H; Liang N; Chen Y; Ma D; Han Z; Xu X; He J; Li S
    Gene; 2018 Oct; 675():278-284. PubMed ID: 29935356
    [TBL] [Abstract][Full Text] [Related]  

  • 2. MiR-504 inhibits cell proliferation and invasion by targeting LOXL2 in non small cell lung cancer.
    Ye MF; Zhang JG; Guo TX; Pan XJ
    Biomed Pharmacother; 2018 Jan; 97():1289-1295. PubMed ID: 29156517
    [TBL] [Abstract][Full Text] [Related]  

  • 3. MiR-181a inhibits non-small cell lung cancer cell proliferation by targeting CDK1.
    Shi Q; Zhou Z; Ye N; Chen Q; Zheng X; Fang M
    Cancer Biomark; 2017 Dec; 20(4):539-546. PubMed ID: 28946554
    [TBL] [Abstract][Full Text] [Related]  

  • 4. MiR-34b-3p represses cell proliferation, cell cycle progression and cell apoptosis in non-small-cell lung cancer (NSCLC) by targeting CDK4.
    Feng H; Ge F; Du L; Zhang Z; Liu D
    J Cell Mol Med; 2019 Aug; 23(8):5282-5291. PubMed ID: 31199581
    [TBL] [Abstract][Full Text] [Related]  

  • 5. MicroRNA-361-3p suppresses tumor cell proliferation and metastasis by directly targeting SH2B1 in NSCLC.
    Chen W; Wang J; Liu S; Wang S; Cheng Y; Zhou W; Duan C; Zhang C
    J Exp Clin Cancer Res; 2016 May; 35():76. PubMed ID: 27164951
    [TBL] [Abstract][Full Text] [Related]  

  • 6. MiR-613 induces cell cycle arrest by targeting CDK4 in non-small cell lung cancer.
    Li D; Li DQ; Liu D; Tang XJ
    Cell Oncol (Dordr); 2016 Apr; 39(2):139-47. PubMed ID: 26744345
    [TBL] [Abstract][Full Text] [Related]  

  • 7. MiR-141-3p functions as a tumor suppressor through directly targeting ZFR in non-small cell lung cancer.
    Li W; Cui Y; Wang D; Wang Y; Wang L
    Biochem Biophys Res Commun; 2019 Feb; 509(3):647-656. PubMed ID: 30611568
    [TBL] [Abstract][Full Text] [Related]  

  • 8. MiRNA-195-5p Functions as a Tumor Suppressor and a Predictive of Poor Prognosis in Non-small Cell Lung Cancer by Directly Targeting CIAPIN1.
    Zheng J; Xu T; Chen F; Zhang Y
    Pathol Oncol Res; 2019 Jul; 25(3):1181-1190. PubMed ID: 30637589
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Down-regulation of miR-675-5p contributes to tumor progression and development by targeting pro-tumorigenic GPR55 in non-small cell lung cancer.
    He D; Wang J; Zhang C; Shan B; Deng X; Li B; Zhou Y; Chen W; Hong J; Gao Y; Chen Z; Duan C
    Mol Cancer; 2015 Apr; 14():73. PubMed ID: 25889562
    [TBL] [Abstract][Full Text] [Related]  

  • 10. MicroRNA-383 is a tumor suppressor and potential prognostic biomarker in human non-small cell lung caner.
    Shang Y; Zang A; Li J; Jia Y; Li X; Zhang L; Huo R; Yang J; Feng J; Ge K; Yang Y; Zhang Y; Jiang J
    Biomed Pharmacother; 2016 Oct; 83():1175-1181. PubMed ID: 27551765
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Knockdown of LncRNA PVT1 inhibits tumorigenesis in non-small-cell lung cancer by regulating miR-497 expression.
    Guo D; Wang Y; Ren K; Han X
    Exp Cell Res; 2018 Jan; 362(1):172-179. PubMed ID: 29133127
    [TBL] [Abstract][Full Text] [Related]  

  • 12. MicroRNA-21 (miR-21) represses tumor suppressor PTEN and promotes growth and invasion in non-small cell lung cancer (NSCLC).
    Zhang JG; Wang JJ; Zhao F; Liu Q; Jiang K; Yang GH
    Clin Chim Acta; 2010 Jun; 411(11-12):846-52. PubMed ID: 20223231
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Direct repression of the oncogene CDK4 by the tumor suppressor miR-486-5p in non-small cell lung cancer.
    Shao Y; Shen YQ; Li YL; Liang C; Zhang BJ; Lu SD; He YY; Wang P; Sun QL; Jin YX; Ma ZL
    Oncotarget; 2016 Jun; 7(23):34011-21. PubMed ID: 27049724
    [TBL] [Abstract][Full Text] [Related]  

  • 14. MicroRNA-100 is a potential molecular marker of non-small cell lung cancer and functions as a tumor suppressor by targeting polo-like kinase 1.
    Liu J; Lu KH; Liu ZL; Sun M; De W; Wang ZX
    BMC Cancer; 2012 Nov; 12():519. PubMed ID: 23151088
    [TBL] [Abstract][Full Text] [Related]  

  • 15. MicroRNA-1298 is downregulated in non-small cell lung cancer and suppresses tumor progression in tumor cells.
    Du Z; Wu J; Wang J; Liang Y; Zhang S; Shang Z; Zuo W
    Diagn Pathol; 2019 Dec; 14(1):132. PubMed ID: 31801557
    [TBL] [Abstract][Full Text] [Related]  

  • 16. MicroRNA-1204 promotes cell proliferation by regulating PITX1 in non-small-cell lung cancer.
    Jiang W; He Y; Shi Y; Guo Z; Yang S; Wei K; Pan C; Xia Y; Chen Y
    Cell Biol Int; 2019 Mar; 43(3):253-264. PubMed ID: 30549141
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Circulating microRNA-590-5p functions as a liquid biopsy marker in non-small cell lung cancer.
    Khandelwal A; Seam RK; Gupta M; Rana MK; Prakash H; Vasquez KM; Jain A
    Cancer Sci; 2020 Mar; 111(3):826-839. PubMed ID: 31520555
    [TBL] [Abstract][Full Text] [Related]  

  • 18. miR Profiling Identifies Cyclin-Dependent Kinase 6 Downregulation as a Potential Mechanism of Acquired Cisplatin Resistance in Non-Small-Cell Lung Carcinoma.
    Bar J; Gorn-Hondermann I; Moretto P; Perkins TJ; Niknejad N; Stewart DJ; Goss GD; Dimitroulakos J
    Clin Lung Cancer; 2015 Nov; 16(6):e121-9. PubMed ID: 25703099
    [TBL] [Abstract][Full Text] [Related]  

  • 19. MicroRNA-92a promotes epithelial-mesenchymal transition through activation of PTEN/PI3K/AKT signaling pathway in non-small cell lung cancer metastasis.
    Lu C; Shan Z; Hong J; Yang L
    Int J Oncol; 2017 Jul; 51(1):235-244. PubMed ID: 28534966
    [TBL] [Abstract][Full Text] [Related]  

  • 20. MiR-93-5p up-regulation is involved in non-small cell lung cancer cells proliferation and migration and poor prognosis.
    Yang W; Bai J; Liu D; Wang S; Zhao N; Che R; Zhang H
    Gene; 2018 Mar; 647():13-20. PubMed ID: 29309884
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 35.